Journal of Pharmacobio-Dynamics
Online ISSN : 1881-1353
Print ISSN : 0386-846X
ISSN-L : 0386-846X
Inhibitory Effects of Histamine H1 Receptor Blocking Drugs on Metabolic Activations of Neutrophils
Katsuhiko TANIGUCHIYasusuke MASUDAKoichiro TAKANAKA
著者情報
キーワード: leukotriene
ジャーナル フリー

1991 年 14 巻 2 号 p. 87-93

詳細
抄録
Inhibitory effects of various histamine receptor-blocking agents including antiallergic agents on metabolic activations of neutrophils were examined by measuring leukotrienes (C4, D4 and E4) formation, arachidonic acid release and superoxide generation. The stimulation of neutrophils by calcium ionophore (A23187) causes the production of leukotrienes concomitantly with the release of arachidonic acid from the cells and these were effectively diminished with a variety of antihistaminic agents. Almost all the histamine H1 receptor-blocking drugs studied here showed as inhibitors of the metabolic activations of neutrophils, although the degree was dependent on the drug concentrations. The order of potency of the inhibitory effects on the arachidonic acid release were : homochlorcyclizine, clemastine, and azelastine (IC50<20μM) > oxatomide (IC50<60μM) and diphenylpyraline >triprolidine, meclizine, diphenhydramine (IC50>100μM). The superoxide generation from neutrophils activated by phorbol 12-myristate 13-acetate was also effectively inhibited by these agents, but generally lower concentrations were required to obtain the same degrees of effects. These results indicated that some of the histamine H1 receptor-blocking drugs, such as clemastine and homochlorcyclizine, may act as inhibitors of formation of leukotrienes at the locus of inflammation.
著者関連情報
© The Pharmaceutical Society of Japan
前の記事 次の記事
feedback
Top